Pure Global AI
Manufacturer profile

SEKISUI DIAGNOSTICS P.E.I INC.

IndonesiaCanada5 products registered
VerifiedKemenkes (Ministry of Health) · official registry
5
Total Products
5
Product Names
1
Product Classes
1
Risk Classes
Regulatory footprint
Search SEKISUI DIAGNOSTICS P.E.I INC. across other regulatory registries
ThailandEuropean UnionColombiaSouth KoreaCanadaEcuador
Risk classification breakdown
Distribution of products across risk classes
Kelas Resiko : B5100.0% of total
Product class portfolio
Products organized by product class
Kelas : 2
ABBOTT Direct Bilirubin, ARCHITECT Hemoglobin A1c, ARCHITECT Hemoglobin A1c Controls, ALINITY c Carbon Dioxide Reagent Kit, ALINITY c Amylase Reagent Kit
5 Products
Recent registrations (5 most recent)
Most recently registered products with Ministry of Health
ABBOTT Direct Bilirubin
May 4, 2023
Class
Kelas : 2
Risk Class
Kelas Resiko : B
ARCHITECT Hemoglobin A1c
Jul 27, 2022
Class
Kelas : 2
Risk Class
Kelas Resiko : B
ARCHITECT Hemoglobin A1c Controls
Jul 22, 2022
Class
Kelas : 2
Risk Class
Kelas Resiko : B
ALINITY c Carbon Dioxide Reagent Kit
Oct 25, 2021
Class
Kelas : 2
Risk Class
Kelas Resiko : B
ALINITY c Amylase Reagent Kit
Jul 2, 2021
Class
Kelas : 2
Risk Class
Kelas Resiko : B
About this profile

SEKISUI DIAGNOSTICS P.E.I INC. from Canada is a medical device manufacturer with 5 registered products in the Indonesia Ministry of Health database through Pure Global AI's free platform. The company produces 5 unique product types across 1 product class.

This page provides comprehensive manufacturer intelligence including complete product portfolio, risk class distribution, and product class analysis. Pure Global AI offers free access to 67,600+ Indonesia medical device registrations, helping global MedTech companies identify manufacturers, analyze portfolios, and discover partnership opportunities efficiently.